If you dispense Class A opioids (drugs listed in Part A of the List of Opioids), you should know that new requirements are now in effect.
As of Oct. 20, 2018, if you dispense any of these medications, you are required to apply a warning sticker to the prescription bottle, container or package you use. You also need to provide the client with a patient information handout. You are responsible for obtaining and producing copies of the sticker and handout to use in your own practice. Both are available on the Government of Canada’s website.
If you administer the medication directly to the client, rather than dispense it, the sticker or handout is not necessary. If you have any questions about the difference between dispensing and administering, see the Medication practice standard and read our FAQs about dispensing opioids and labels.
This new requirement is a result of government efforts to increase client access to clear information about the safe use of opioids. This change comes from new laws under the Food and Drug Regulations and affects all health care professionals who dispense Class A opioids. For more information, read Health Canada's Q&As about prescription opioids.